A flanking attack on cancer

被引：67

作者：

Hanahan, D ^{[1
]}

机构：

[1] Univ Calif San Francisco, Hormone Res Inst, Dept Biochem & Biophys, San Francisco, CA 94143 USA

来源：

NATURE MEDICINE | 1998年 / 4卷 / 01期

关键词：

D O I：

10.1038/nm0198-013

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Solid tumors in mice treated with several cycles of the angiogenesis inhibitor endostatin regress, do not develop drug resistance, and eventually fail to recur.

引用

页码：13 / 14

页数：2

共 12 条

[1] Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
Boehm, T
Folkman, J
Browder, T
OReilly, MS
[J]. NATURE, 1997, 390 (6658) : 404 - 407
[2] FOLKMAN J, 1989, J NATL CANCER I, V82, P4
[3] Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D
Folkman, J
[J]. CELL, 1996, 86 (03) : 353 - 364
[4] HANAHAN D, 1997, SCIENCE, V277, P46
[5] DORMANCY OF MICROMETASTASES - BALANCED PROLIFERATION AND APOPTOSIS IN THE PRESENCE OF ANGIOGENESIS SUPPRESSION
HOLMGREN, L
OREILLY, MS
FOLKMAN, J
[J]. NATURE MEDICINE, 1995, 1 (02) : 149 - 153
[6] JAIN RK, 1988, CANCER RES, V48, P2264
[7] A cancer therapy resistant to resistance
Kerbel, RS
[J]. NATURE, 1997, 390 (6658) : 335 - 336
[8] Angiostatin induces and sustains dormancy of human primary tumors in mice
OReilly, MS
Holmgren, L
Chen, C
Folkman, J
[J]. NATURE MEDICINE, 1996, 2 (06) : 689 - 692
[9] Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
OReilly, MS
Boehm, T
Shing, Y
Fukai, N
Vasios, G
Lane, WS
Flynn, E
Birkhead, JR
Olsen, BR
Folkman, J
[J]. CELL, 1997, 88 (02) : 277 - 285
[10] CONSEQUENCES OF ANGIOGENESIS FOR TUMOR PROGRESSION, METASTASIS AND CANCER-THERAPY
RAK, JW
STCROIX, BD
KERBEL, RS
[J]. ANTI-CANCER DRUGS, 1995, 6 (01) : 3 - 18

← 1 2 →